FDA Clearance Tracker · P100045-S086
Next Gen Patient System CM1200 CardioMEMS HERO Device
Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2026
Approved
Time to decision
182 days
Received Aug 29, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P100045-S086
- Device name
- Next Gen Patient System CM1200 CardioMEMS HERO Device
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Atlanta, GA
- Received
- Aug 29, 2025
- Decided
- Feb 27, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P100045
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the CardioMEMS HERO Device, a new version of the patient electronics system.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.